{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:06:55Z","timestamp":1789992415567,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neuropharm.2019.01.033","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:12:05Z","timestamp":1549019525000},"page":"366-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Membrane potential changes occurring upon acidification influence the binding of small-molecule inhibitors to ASIC1a"],"prefix":"10.1016","volume":"148","author":[{"given":"Nausicaa","family":"Mazzocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Grohovaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Taverna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-756X","authenticated-orcid":false,"given":"Andrea","family":"Menegon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.01.033_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cell.2014.01.011","article-title":"X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel","volume":"156","author":"Baconguis","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2015.01.005","article-title":"Pharmacology of acid-sensing ion channels - physiological and therapeutical perspectives","volume":"94","author":"Baron","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/jphysiol.2001.014837","article-title":"ASIC-like, proton-activated currents in rat hippocampal neurons","volume":"539","author":"Baron","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib4","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1073\/pnas.1324060111","article-title":"Acid-sensing ion channel (ASIC) 1a\/2a heteromers have a flexible 2:1\/1:2 stoichiometry","volume":"111","author":"Bartoi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuropharm.2017.08.004","article-title":"Pharmacological modulation of acid-sensing ion channels 1a and 3 by amiloride and 2-guanidine-4-methylquinazoline (GMQ)","volume":"125","author":"Besson","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib6","doi-asserted-by":"crossref","first-page":"27311","DOI":"10.1074\/jbc.M115.665000","article-title":"Membrane potential controls the efficacy of catecholamine-induced \u03b21-adrenoceptor activity","volume":"290","author":"Birk","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib7","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bph.13533","article-title":"The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na + channel (ENaC): IUPHAR Review 19","volume":"173","author":"Boscardin","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbi.2014.12.003","article-title":"Down-sizing of neuronal network activity and density of presynaptic terminals by pathological acidosis are efficiently prevented by Diminazene Aceturate","volume":"45","author":"de Ceglia","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib9","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/s41598-017-05128-z","article-title":"Structural determinants at the M2 muscarinic receptor modulate the RGS4-GIRK response to pilocarpine by impairment of the receptor voltage sensitivity","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2010.09.005","article-title":"Design and screening of ASIC inhibitors based on aromatic diamidines for combating neurological disorders","volume":"648","author":"Chen","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuropharm.2010.01.011","article-title":"Diarylamidines: high potency inhibitors of acid-sensing ion channels","volume":"58","author":"Chen","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00010.2003","article-title":"Regulation and modulation of pH in the brain","volume":"83","author":"Chesler","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib13","first-page":"288","article-title":"Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential","volume":"3","author":"Chu","year":"2011","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuropharm.2017.04.042","article-title":"Acid-sensing ion channel (ASIC) structure and function: insights from spider, snake and sea anemone venoms","volume":"127","author":"Cristofori-Armstrong","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1471-4159.2008.05412.x","article-title":"Mechanisms of non-steroid anti-inflammatory drugs action on ASICs expressed in hippocampal interneurons","volume":"106","author":"Dorofeeva","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/nm1668","article-title":"Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system","volume":"13","author":"Friese","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1085\/jgp.200810002","article-title":"Voltage- and [ATP]-dependent gating of the P2X 2 ATP receptor channel","volume":"133","author":"Fujiwara","year":"2009","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2014.12.016","article-title":"Biophysical properties of acid-sensing ion channels (ASICs)","volume":"94","author":"Gr\u00fcnder","year":"2015","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2019.01.033_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nbt1194","article-title":"Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential","volume":"24","author":"Huang","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib21","doi-asserted-by":"crossref","first-page":"27647","DOI":"10.1038\/srep27647","article-title":"Functional and pharmacological characterization of two different ASIC1a\/2a heteromers reveals their sensitivity to the spider toxin PcTx1","volume":"6","author":"Joeres","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jmb.2014.06.004","article-title":"Architectural and functional similarities between trimeric ATP-gated P2X receptors and acid-sensing ion channels","volume":"427","author":"Kellenberger","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.114.009225","article-title":"International Union of Basic and Clinical Pharmacology. XCI. structure, function, and pharmacology of acid-sensing ion channels and the epithelial Na+ channel","volume":"67","author":"Kellenberger","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196894","article-title":"Molecular basis of inhibition of acid sensing ion channel 1A by diminazene","volume":"13","author":"Krauson","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib25","doi-asserted-by":"crossref","first-page":"34375","DOI":"10.1074\/jbc.M113.504324","article-title":"Independent contribution of extracellular proton binding sites to ASIC1a activation","volume":"288","author":"Krauson","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib26","doi-asserted-by":"crossref","first-page":"42635","DOI":"10.1074\/jbc.M111.289058","article-title":"Nonproton ligand sensing domain is required for paradoxical stimulation of acid-sensing ion channel 3 (ASIC3) channels by amiloride","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib27","doi-asserted-by":"crossref","first-page":"16315","DOI":"10.1074\/jbc.M109.092015","article-title":"A combined computational and functional approach identifies new residues involved in pH-dependent gating of ASIC1a","volume":"285","author":"Liechti","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/wmts.88","article-title":"Pharmacology of ASIC channels","volume":"2","author":"Lingueglia","year":"2013","journal-title":"Wiley Interdiscip. Rev. Membr. Transp. Signal."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1087057115617455","article-title":"Fluorescence-based automated screening assay for the study of the pH-sensitive channel ASIC1a","volume":"21","author":"Mazzocchi","year":"2016","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib30","doi-asserted-by":"crossref","first-page":"11670","DOI":"10.1523\/JNEUROSCI.3321-06.2006","article-title":"Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity","volume":"26","author":"Menegon","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib31","doi-asserted-by":"crossref","first-page":"44843","DOI":"10.1038\/srep44843","article-title":"A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels","volume":"7","author":"Menegon","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/brain\/awl325","article-title":"Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia","volume":"130","author":"Pignataro","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib33","doi-asserted-by":"crossref","first-page":"C943","DOI":"10.1152\/ajpcell.00019.2012","article-title":"ENaCs and ASICs as therapeutic targets","volume":"302","author":"Qadri","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.neuropharm.2019.01.033_bib34","first-page":"756","article-title":"Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs","volume":"40","author":"Ragsdale","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib35","doi-asserted-by":"crossref","first-page":"35896","DOI":"10.1074\/jbc.M113.478982","article-title":"Proton-mediated conformational changes in an acid-sensing ion channel","volume":"288","author":"Ramaswamy","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib36","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1073\/pnas.1212656110","article-title":"Voltage regulates adrenergic receptor function","volume":"110","author":"Rinne","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.neuropharm.2019.01.033_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/187220830901151111124125","article-title":"A review of recent patents on the ASICs as a key drug target","volume":"9","author":"Santos","year":"2015","journal-title":"Recent Pat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.117.110064","article-title":"Diminazene is a slow pore blocker of acid-sensing ion channel 1a (ASIC1a)","volume":"92","author":"Schmidt","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2019.01.033_bib40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1113\/jphysiol.1996.sp021417","article-title":"Effects of extracellular pH on voltage-gated Na+, K+ and Ca2+ currents in isolated rat CA1 neurons","volume":"493","author":"Tombaugh","year":"1996","journal-title":"J. Physiol."},{"issue":"6621","key":"10.1016\/j.neuropharm.2019.01.033_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/386173a0","article-title":"A proton-gated cation channel involved in acid sensing","volume":"386","author":"Waldmann","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrn3529","article-title":"Acid-sensing ion channels in pain and disease","volume":"14","author":"Wemmie","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.033_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13041-016-0185-7","article-title":"ASIC subunit ratio and differential surface trafficking in the brain","volume":"9","author":"Wu","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","article-title":"Neuroprotection in ischemia","volume":"118","author":"Xiong","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2019.01.033_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-6-1","article-title":"Acid-sensing ion channels: trafficking and synaptic function","volume":"6","author":"Zha","year":"2013","journal-title":"Mol. Brain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818307780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818307780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T17:37:12Z","timestamp":1573839432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818307780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"alternative-id":["S0028390818307780"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.033","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane potential changes occurring upon acidification influence the binding of small-molecule inhibitors to ASIC1a","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}